iSpecimen Inc. received a formal notice from Nasdaq on May 29, 2026, regarding non-compliance with Listing Rule 5550(b)(1). The rule requires a minimum of $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market. As of March 31, 2026, the company reported stockholders' equity of $814,038, falling significantly below the required threshold. The company does not currently meet alternative listing standards, including market value or net income requirements. The company has 45 days to submit a compliance plan to Nasdaq.